Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

THE TREATMENT OF ACUTE RHEUMATIC FEVER WITH PENICILLIN

THE TREATMENT OF ACUTE RHEUMATIC FEVER WITH PENICILLIN The probable relationship of Lancefield group A hemolytic streptococcic disease to rheumatic fever has led to the therapeutic trial of various antistreptococcic substances in this disease. Swift1 and Jones2 have described the effects of sulfanilamide in acute rheumatic fever. Swift3 and his co-workers4 have also reported the results of streptococcic antiserums in.this disease. Both of these entirely unrelated substances were found to be of no therapeutic value, and the evidence is suggestive that at times they may have been harmful. In view of these observations, when penicillin became available there was little cause for optimism that it would be beneficial in this disease. However, because of the great need for a more satisfactory therapeutic agent for rheumatic fever and the knowledge that the value of penicillin in this disease would eventually need to be determined, it was felt that an organized study by producing an answer http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

THE TREATMENT OF ACUTE RHEUMATIC FEVER WITH PENICILLIN

Loading next page...
 
/lp/american-medical-association/the-treatment-of-acute-rheumatic-fever-with-penicillin-2QRFg0RIbD

References (2)

Publisher
American Medical Association
Copyright
Copyright © 1944 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1944.02850400013004
Publisher site
See Article on Publisher Site

Abstract

The probable relationship of Lancefield group A hemolytic streptococcic disease to rheumatic fever has led to the therapeutic trial of various antistreptococcic substances in this disease. Swift1 and Jones2 have described the effects of sulfanilamide in acute rheumatic fever. Swift3 and his co-workers4 have also reported the results of streptococcic antiserums in.this disease. Both of these entirely unrelated substances were found to be of no therapeutic value, and the evidence is suggestive that at times they may have been harmful. In view of these observations, when penicillin became available there was little cause for optimism that it would be beneficial in this disease. However, because of the great need for a more satisfactory therapeutic agent for rheumatic fever and the knowledge that the value of penicillin in this disease would eventually need to be determined, it was felt that an organized study by producing an answer

Journal

JAMAAmerican Medical Association

Published: Sep 30, 1944

There are no references for this article.